Ortizo, Rubie .
HRN: 10-43-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2023
CEFUROXIME 500MG (TAB)
10/31/2023
11/07/2023
PO
500mg Tab
BID
Prom X 21 Hours, Post Nsvd
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes